S

Scandinavian Medical Solutions A/S
F:K41

Watchlist Manager
Scandinavian Medical Solutions A/S
F:K41
Watchlist
Price: 0.366 EUR 0.27% Market Closed
Market Cap: €10.1m

Wall St Price Targets

K41 Price Targets Summary
Scandinavian Medical Solutions A/S

Wall Street analysts forecast K41 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for K41 is 0.549 EUR with a low forecast of 0.543 EUR and a high forecast of 0.565 EUR.

Lowest Forecast
Price Target
0.543 EUR
48% Upside
Average Forecast
Price Target
0.549 EUR
50% Upside
Highest Forecast
Price Target
0.565 EUR
54% Upside
Scandinavian Medical Solutions A/S Competitors:
Price Targets

Revenue
Forecast

36% / Year
Past Growth
9% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
36% / Year
Past Growth
9% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 4 years, the compound annual growth rate for Revenue has been 36%. The projected CAGR for the next 3 years is 9%.

Gross Profit
Forecast

35% / Year
Past Growth
0% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
35% / Year
Past Growth
0% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 4 years, the compound annual growth rate for Gross Profit has been 35%. The projected CAGR for the next 3 years is 0%.

Operating Income
Forecast

-36% / Year
Past Growth
132% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
-36% / Year
Past Growth
132% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 4 years, the compound annual growth rate for Operating Income has been -36%. The projected CAGR for the next 3 years is 132%.

Pre-Tax Income
Forecast

-62% / Year
Past Growth
323% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
-62% / Year
Past Growth
323% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 4 years, the compound annual growth rate for Pre-Tax Income has been -62%. The projected CAGR for the next 3 years is 323%.

Net Income
Forecast

-76% / Year
Past Growth
753% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
-76% / Year
Past Growth
753% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 4 years, the compound annual growth rate for Net Income has been -76%. The projected CAGR for the next 3 years is 753%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is K41's stock price target?
Price Target
0.549 EUR

According to Wall Street analysts, the average 1-year price target for K41 is 0.549 EUR with a low forecast of 0.543 EUR and a high forecast of 0.565 EUR.

What is the Revenue forecast for Scandinavian Medical Solutions A/S?
Projected CAGR
9%

Over the last 4 years, the compound annual growth rate for Revenue has been 36%. The projected CAGR for the next 3 years is 9%.

What is the Gross Profit forecast for Scandinavian Medical Solutions A/S?
Projected CAGR
0%

Over the last 4 years, the compound annual growth rate for Gross Profit has been 35%. The projected CAGR for the next 3 years is 0%.

What is the Operating Income forecast for Scandinavian Medical Solutions A/S?
Projected CAGR
132%

Over the last 4 years, the compound annual growth rate for Operating Income has been -36%. The projected CAGR for the next 3 years is 132%.

What is the Pre-Tax Income forecast for Scandinavian Medical Solutions A/S?
Projected CAGR
323%

Over the last 4 years, the compound annual growth rate for Pre-Tax Income has been -62%. The projected CAGR for the next 3 years is 323%.

What is the Net Income forecast for Scandinavian Medical Solutions A/S?
Projected CAGR
753%

Over the last 4 years, the compound annual growth rate for Net Income has been -76%. The projected CAGR for the next 3 years is 753%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett